UPDATE: RBC Capital Markets Upgrades AVEO Pharmaceuticals On Progress In Multiple Areas

By: via Benzinga
In a report published Monday, RBC Capital Markets analyst Adnan Butt upgraded the rating on AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.